NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of CPI Card Group Inc. ("CPI" or the "Company") (NASDAQ:PMTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether CPI and certain of its officers […]
NEW YORK, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Align Technology, Inc. ("Align" or the "Company") (NASDAQ:ALGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Align and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Axogen, Inc. ("Axogen" or the "Company") (NASDAQ:AXGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Axogen and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Snap, Inc. ("Snap" or the "Company") (NYSE:SNAP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against KinderCare Learning Companies, Inc.("KinderCare" or the "Company") (NYSE:KLC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Replimune Group, Inc.("Replimune" or the "Company") (NASDAQ:REPL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ:CAPR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Capricor and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against XPLR Infrastructure, LP ("XPLR" or the "Company") (NYSE:XIFR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Charter Communications, Inc. ("Charter" or the "Company") (NASDAQ:CHTR).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc.("Agios" or the "Company") (NASDAQ:AGIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Agios and certain of its officers and/or directors